This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Reddel, S W Articles by Krilis, S A Search for Related Content PubMed PubMed Citation Articles by Reddel, S W Articles by Krilis, S A Social Bookmarking                         What's this?

Anti-ß2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding

Faculty of Medicine and Department of Immunology, Allergy and Infectious Diseases, St George Hospital, University of New South Wales, Sydney, Australia

Y X Wang

Faculty of Medicine and Department of Immunology, Allergy and Infectious Diseases, St George Hospital, University of New South Wales, Sydney, Australia

S A Krilis

Faculty of Medicine and Department of Immunology, Allergy and Infectious Diseases, St George Hospital, University of New South Wales, Sydney, Australia, s.krilis{at}unsw.edu.au

Autoantibodies binding ß₂-glycoprotein I (B2GPI) are an important finding in the antiphospholipid syndrome. While antibodies from mice or rabbits immunized with B2GPI readily bind B2GPI coated on a polystyrene microwell plate, anti-B2GPI autoantibodies only do so when using a modified microwell plate with a negatively charged surface.

This study demonstrates that, for the detection of anti-B2GPI autoantibodies in an ELISA using modified plates, an antigen coating concentration threshold exists, such that minimal or no binding occurs below a certain coating concentrationof antigen, even though antigen is easily demonstrable on the plate. This is consistent with the hypothesis that autoantibodies require divalent binding to B2GPI for detection, as sufficient antigen density for two protein molecules to be sufficiently close to enable divalent binding would only be expected to occur at higher coating concentrations.

Several mutant forms of B2GPI developed for epitope determination experiments are shown to have decreased binding to microtitre plates compared to wild-type. If wild-type and mutants are assayed for antibody binding near the threshold a significant diminution in binding to mutants occurs that is the result of inadequate binding to the plate, but could be misinterpreted as the result of interruption of an epitope by the mutation.

Key Words: antibodies • antiphospholipid syndrome • divalent binding • epitope • ß2-glycoprotein I

Lupus, Vol. 12, No. 1, 37-45 (2003)
DOI: 10.1191/0961203303lu280oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. Gaspersic, A. Ambrozic, B. Bozic, J. Majhenc, S. Svetina, and B. Rozman Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-{beta}2-glycoprotein I and anti-annexin A5 antibodies Rheumatology, January 1, 2007; 46(1): 81 - 86. [Abstract] [Full Text] [PDF]

				B. de Laat, R. H. W. M. Derksen, M. van Lummel, M. T. T. Pennings, and P. G. de Groot Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change Blood, March 1, 2006; 107(5): 1916 - 1924. [Abstract] [Full Text] [PDF]

				S Cucnik, T Kveder, I Krizaj, B Rozman, and B Bozic High avidity anti-{beta}2-glycoprotein I antibodies in patients with antiphospholipid syndrome Ann Rheum Dis, November 1, 2004; 63(11): 1478 - 1482. [Abstract] [Full Text] [PDF]

				S. Cucnik, T. Kveder, B. Rozman, and B. Bozic Binding of high-avidity anti-{beta}2-glycoprotein I antibodies Rheumatology, November 1, 2004; 43(11): 1353 - 1356. [Abstract] [Full Text] [PDF]